Inside a plant in China producing the WHO-approved Sinovac Covid-19 vaccine 在中國一家生產世衛組織批准的 Sinovac Covid-19 疫苗的工廠內

English:

South China Morning Post shows that the WHO approval of Sinovac Biotech’s coronavirus vaccine for emergency use on June 1, 2021, will help ease the global vaccine shortage. Sinovac Biotech has already distributed more than 600 million doses of its CoronaVac vaccine to nearly 40 countries, as of May 31, 2021. It uses an inactivated virus to trigger a protective immune response, unlike vaccines from companies like BioNTech, which feature newer mRNA technology. The Post takes a look inside their Beijing plant.

Chinese:

南華早報顯示，世衛組織於2021年6月1日批准科興生物的冠狀病毒疫苗緊急使用，將有助於緩解全球疫苗短缺。 截至 2021 年 5 月 31 日，Sinovac Biotech 已向近 40 個國家/地區分發了超過 6 億劑 CoronaVac 疫苗。它使用滅活病毒來觸發保護性免疫反應，這與 BioNTech 等公司的疫苗不同，後者採用更新的 mRNA 技術 . 郵報參觀了他們北京的工廠。

Useful Translations: 有用的翻譯:

Nouns:

鳥 bird

病毒 virus

細菌 bacterium, germ, virus

惡毒 malignity, gall, virus

病毒株 virus strain

病毒傳播 virus spread

流行性 epidemic

大流行病 pandemic